Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy-Reference-Cited by-同舟云学术

Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy

Published:2020-03-20 Issue:6 Volume:95 Page:612-622
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Montalban‐Bravo Guillermo¹^ORCID,Kanagal‐Shamanna Rashmi²^ORCID,Class Caleb A.³,Sasaki Koji¹,Ravandi Farhad¹,Cortes Jorge E.¹,Daver Naval¹^ORCID,Takahashi Koichi¹,Short Nicholas J.¹^ORCID,DiNardo Courtney D.¹^ORCID,Jabbour Elias¹^ORCID,Borthakur Gautam¹^ORCID,Naqvi Kiran¹,Issa Ghayas C.¹,Konopleva Marina¹^ORCID,Khoury Joseph D.¹^ORCID,Routbort Mark¹,Pierce Sherry¹,Do Kim‐Anh³,Bueso‐Ramos Carlos²,Patel Keyur²,Kantarjian Hagop¹^ORCID,Garcia‐Manero Guillermo¹,Kadia Tapan M.¹^ORCID

Affiliation:

1. Department of LeukemiaThe University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of HematopathologyThe University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of BiostatisticsThe University of Texas MD Anderson Cancer Center Houston Texas USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25769

Reference29 articles.

1. Acute Myeloid Leukemia

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

4. Acute Myeloid Leukemia With Myelodysplasia-Related Changes

5. The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study;Leukemia & Lymphoma;2024-08-10

2. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics;International Journal of Molecular Sciences;2024-04-11

3. A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia;International Journal of Hematology;2024-03-26

4. Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine;Hematology;2024-03-03

5. Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy;Cancer Medicine;2024-02